HIV Infection and Subclinical Coronary Atherosclerosis
A letter discussing coronary atherosclerosis in people living with HIV
View PublicationA letter discussing coronary atherosclerosis in people living with HIV
View PublicationExploring HIV-positive women’s meaningful involvement in the design and delivery of HIV/AIDS services in British Columbia, Canada
View PublicationInvestigating whether improvements in HIV treatment have led to declines in risk of end-stage renal disease
View PublicationDesigning a study to assess supplementation with an extended-release form of niacin in combination with ART, compared to ART alone, on T-cell immune activation
View PublicationEstimating trends and predictors of treatment interruption and resumption
View PublicationCompare participants to the general population to determine if co-infected patients have had similar improvements in mortality
View PublicationMonitoring the impact of IFN-α on T cell phenotype and proliferation of HIV and HCV-specific T cells during IFN therapy
View PublicationInvestigating the impact of early cART initiation on measures of HIV-1 reservoir size in HIV-1–infected children with sustained virologic suppression
View Publication